RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:231111

Drug-induced lupus erythematosus

low confidenceDisorder

Also known as: DILE

Publications

2,153

Trials

0

Interventional, condition-specific

Researchers

972

Distinct authors in sample

Gene link

—

Readiness

2/6

Stages with a signal

Clinical definition (Orphanet)

A rare, systemic disease with skin involvement characterized by the onset of lupus erythematosus-like signs and symptoms resulting from continuous drug intake (>1 month), which resolve when treatment is discontinued, in persons with no history of autoimmune disease. Manifestations are variable and may be systemic (e.g. arthralgia, myalgia, fever, fatigue, serositis, pleuritis, pericarditis), subacute cutaneous (incl. photosensitive, non-scarring, annular, polycyclic or papulosquamous lesions, malar erythema, vasculitis, bullous lesions, erythema multiforme-like changes), and/or chronic cutaneous (typically discoid lesions in sun-exposed areas). Procainamide and hydralazine are the drugs most frequently implicated.

How rare: How common this is has not been clearly measured.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (3)

drug induced lupus · drug induced lupus erythematosus · drug-induced lupus

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

2/6 stages with a signal

No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    2,153 matched papers (1,018 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialPartial

    None under the specific name; 918 for broader category lupus erythematosus

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

2,153

2,153 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

2,153 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

1,018 in the last 10 years · low confidence

Phrase hits: 2,153 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

972

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Lee AYS4 papers · 2026

    Institute of Clinical Pathology and Medical Research/Westmead Hospital.

    Papers in Europe PMC
  2. 02
    Bains K3 papers · 2026

    Department of Internal Medicine, Banner University Medical Center, Tucson, AZ, USA.

    Papers in Europe PMC
  3. 03
    Barbaud A3 papers · 2022

    Faculté de Médecine Sorbonne Université, AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France.

    Papers in Europe PMC
  4. 04
    Chasset F3 papers · 2022

    Faculté de Médecine Sorbonne Université, AP-HP, Service de Dermatologie et Allergologie, Hôpital Tenon, Paris, France.

    Papers in Europe PMC
  5. 05
    Liu J3 papers · 2025

    Department of Gastroenterology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, China.

    Papers in Europe PMC
  6. 06
    Manzo C3 papers · 2021

    Gerontorheumatologic Outpatient Service, Mariano Lauro Hospital, Naples 80063, Italy.

    Papers in Europe PMC
  7. 07
    Minchenberg SB3 papers · 2026

    Division of Gastroenterology & Hepatology, Beth Israel Deaconess Medical Center, Boston, MA, 02115, USA.

    Papers in Europe PMC
  8. 08
    Prabakaran S3 papers · 2026

    NonExomics, Inc.,, 2 Simon Willard Road, Acton, MA, 01720, USA. sudhakaran.prabakaran@nonexomics.com.

    Papers in Europe PMC
  9. 09
    Sudhakaran SC3 papers · 2026

    Acton-Boxborough Regional High School, Acton, MA, 01720, USA.

    Papers in Europe PMC
  10. 10
    Wayland MT3 papers · 2026

    Department of Zoology, University of Cambridge, Downing Street, Cambridge, CB2 3EJ, UK.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 918 trials are registered for lupus erythematosus, the broader category — shown separately because they may or may not enrol this specific subtype.

Data as of 27 July 2026

No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.

low confidence · 36.5th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

918 interventional trials matched lupus erythematosus, the broader category — listed below. Those studies are not counted in the condition-specific total.

Broader category: lupus erythematosus

918

Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.

Worth raising with a clinician. How we count trials.

Recruiting under the broader category

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Drug-induced lupus erythematosus" OR "drug induced lupus" OR "drug induced lupus erythematosus" OR "drug-induced lupus"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Drug-induced lupus erythematosus" OR "drug induced lupus" OR "drug induced lupus erythematosus" OR "drug-induced lupus"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Parent-category trials query:

"lupus erythematosus"

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Synonyms dropped by stoplist: DILE

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • 1 synonym(s) dropped by stoplist (may under-count)
  • No label/synonym collisions with other diseases in this corpus
  • Publication count (2153) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity

Ingested 2026-07-27T10:13:11.427Z